Ethris GmbH

Quick facts

Phase 2 pipeline

• ETH47 · Infectious Diseases
  ETH47 is a small molecule that targets the SARS-CoV-2 main protease.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Ethris GmbH portfolio CI brief
• Ethris GmbH pipeline updates RSS